Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/08/1997CA2194656A1 Partially lyophilized fructose-1,6-diphosphate (fdp) for injection into humans
11/06/1997WO1997041443A2 Method for screening compounds
11/06/1997WO1997041440A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997WO1997041263A1 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
11/06/1997WO1997041252A2 Dna, rna and a protein useful for detection of a mycobacterial infection
11/06/1997WO1997041243A2 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene
11/06/1997WO1997041236A1 Polynucleotide vaccine against canine distemper
11/06/1997WO1997041230A2 Cc-type chemokines
11/06/1997WO1997041225A2 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr]
11/06/1997WO1997041222A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
11/06/1997WO1997041211A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them
11/06/1997WO1997041210A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/06/1997WO1997041206A2 Von willebrand factor multimerase
11/06/1997WO1997041201A1 Anol esters as bleach activators for detergents and cleaners
11/06/1997WO1997041156A1 Novel compounds
11/06/1997WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997WO1997041148A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants
11/06/1997WO1997041147A1 Novel compounds
11/06/1997WO1997041146A1 Novel compounds
11/06/1997WO1997041145A1 21-substituted progesterone derivatives as new antiprogestational agents
11/06/1997WO1997041144A1 Novel steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
11/06/1997WO1997041141A1 Methods and compounds for curing diseases caused by mutations
11/06/1997WO1997041129A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
11/06/1997WO1997041127A1 Halo-substituted protein kinase c inhibitors
11/06/1997WO1997041125A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
11/06/1997WO1997041123A1 1-methylcarbapenem derivatives
11/06/1997WO1997041121A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
11/06/1997WO1997041120A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
11/06/1997WO1997041119A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
11/06/1997WO1997041115A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
11/06/1997WO1997041114A1 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
11/06/1997WO1997041108A1 Substituted piperazines and piperidines as central nervous system agents
11/06/1997WO1997041104A1 Quinoline derivatives, processes for their preparation, and their use as medicaments
11/06/1997WO1997041103A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997WO1997041102A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
11/06/1997WO1997041099A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997WO1997041098A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997WO1997041097A2 Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
11/06/1997WO1997041096A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
11/06/1997WO1997041090A1 Inorganic ion receptor-active compounds
11/06/1997WO1997040861A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997WO1997040857A1 Drug delivery using terminal complement components
11/06/1997WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997WO1997040854A2 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997WO1997040849A1 Method for treating or preventing ischemia-reperfusion injury
11/06/1997WO1997040848A1 Use of prolactin as a tgf-beta antagonist
11/06/1997WO1997040842A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/06/1997WO1997040841A1 Use of formes f hyaluronic acid (ha) for the treatment of cancer
11/06/1997WO1997040840A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
11/06/1997WO1997040839A1 Dna vaccine formulations
11/06/1997WO1997040838A1 New use
11/06/1997WO1997040837A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997WO1997040836A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
11/06/1997WO1997040835A1 Treatment of carcinomas using squalamine in combination with other anti-cancer agents
11/06/1997WO1997040834A1 Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines
11/06/1997WO1997040833A1 Hiv protease inhibitors useful for the treatment of aids
11/06/1997WO1997040832A1 Use of dipeptidyl peptidase iv effectors for lowering the blood glucose level in mammals
11/06/1997WO1997040831A1 Therapeutic treatment for vegf related occular diseases
11/06/1997WO1997040830A1 Therapeutic treatment for vegf related diseases
11/06/1997WO1997040829A1 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy
11/06/1997WO1997040828A1 Rapid-release s1452 tablets
11/06/1997WO1997040827A1 Use of ethylene diamine disuccinate for preparing a medicament with antiviral properties
11/06/1997WO1997040826A1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
11/06/1997WO1997040825A1 Hiv protease inhibitors useful for the treatment of aids
11/06/1997WO1997040824A2 Propellant mixtures and aerosols for micronising medicaments with compressed gas
11/06/1997WO1997040823A1 Oral pharmaceutical compositions containing sex hormones
11/06/1997WO1997040819A1 Methods of dry powder inhalation
11/06/1997WO1997040818A1 Biologically active composition
11/06/1997WO1997040813A1 Composition, barrier film, and method for preventing contact dermatitis
11/06/1997WO1997040792A1 Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers
11/06/1997WO1997040776A1 Synchronising of animal oestrus and intra vaginal devices useful therein
11/06/1997WO1997040680A1 Antioxidant compound
11/06/1997WO1997036595A3 Medicament preparations containing tumour-inhibiting ruthenium (iii) complexes
11/06/1997WO1997035969A3 Peptide ligands of the urokinase receptor
11/06/1997WO1997034569A3 Pyronin antibacterials, process and intermediates
11/06/1997WO1997033608A3 Antagonism of endothelin actions
11/06/1997WO1997033566A3 Composition and dosage form comprising opioid antagonist
11/06/1997DE19705277A1 Formulation for topical treatment of recurrent herpes diseases
11/06/1997DE19616693A1 Enolester als Bleichaktivatoren für Wasch- und Reinigungsmittel Enol esters as bleach activators for washing and cleaning agents
11/06/1997DE19616573A1 Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase Propellant mixtures and aerosols for the micronization of drugs using dense gases
11/06/1997CA2668824A1 21-substituted progesterone derivatives as new antiprogestational agents
11/06/1997CA2253608A1 Therapeutic treatment for vegf related diseases
11/06/1997CA2253440A1 New use
11/06/1997CA2253433A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997CA2253346A1 Novel steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
11/06/1997CA2253313A1 Method for treating or preventing ischemia-reperfusion injury
11/06/1997CA2253300A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997CA2253288A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents
11/06/1997CA2253282A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997CA2253263A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/06/1997CA2253252A1 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997CA2253229A1 Polynucleotide vaccine against canine distemper
11/06/1997CA2252962A1 Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines
11/06/1997CA2252918A1 Hiv protease inhibitors useful for the treatment of aids
11/06/1997CA2252915A1 Hiv protease inhibitors useful for the treatment of aids
11/06/1997CA2252876A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
11/06/1997CA2252869A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997CA2252862A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
11/06/1997CA2252814A1 Methods of dry powder inhalation
11/06/1997CA2252779A1 Use of ethylene diamine disuccinate for preparing a medicament with antiviral properties